Nagase & Co., Ltd. (8012.T) fair value

ACCE thesis

Nagase is a Tokyo-listed trading house whose core business is distributing specialty chemicals, plastics, and electronic materials, alongside its own pharmaceutical intermediates and resins manufacturing through subsidiaries in Japan and Asia. The moat is in the distribution network itself: long-standing supplier relationships and a dense sales footprint that let it place formulated materials with manufacturers who would rather not qualify a new source. Revenue grew 17.9% on the latest figures, and the forward P/E of 3.9 against a trailing 12.5 implies the market expects earnings to rise sharply from here, though that gap is wide enough that it deserves checking against consensus before anyone leans on it. At a 6.1% operating margin and a 9.6% ROE, the business is thin-margin and not yet a high-return compounder, so the case rests on whether volume growth and mix shift can lift profitability. The name is worth a deeper look for that specific question, which a PM can test in the filings, not on the headline multiple alone.